This page is part of the Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Profile: Barbiturate Medication Profile
code: acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Capacet]
status: Active